A cystic fibrosis drug that is expected to be taken by only a few hundred people may drain almost $36 million from California's general fund over two fiscal years.
Congressional investigators have pried loose emails showing how the company's executives anticipated huge profits from a 5,000 percent drug price increase. They were blindsided by the blowback.
The generic form of the blockbuster cancer drug is being shipped to pharmacies. The generic is likely to cost 30 percent less than the brand-name version, but Gleevec's price doubled in recent years.
Effective treatments for hepatitis C cost as much as $95,000. Medicaid in many states, including Indiana, is mostly limiting the drugs' use to very advanced cases. ACLU of Indiana is suing the state.
Medicare insurance plans for drugs vary widely in the medicines they cover. For 2016, some patients who pick the wrong plan could pay nearly $12,000 out of pocket annually for a single drug.
Many covered medicines come with high out-of-pocket costs for patients, the American Cancer Society says in a report that calls for restrictions on the tabs insurers can pass along to patients.
The website Iodine has collected data about consumers' experience with prescription drugs that show generics scored highest among people who take medicines in three popular categories.
Advertising for products to treat symptoms of menopause is becoming much more upfront about issues like painful sex. But more than a few of the remedies are solutions in search of a problem.
Independent pharmacies are getting pinched by reimbursements for generic drugs that aren't keeping up with rising prices. Drugstores blame the middlemen who manage companies' drug benefits.